Latvia Pharmaceuticals & Healthcare Report Q4 2013 - New Market Research Report
After several years of budget cuts, which have had an impact on the healthcare sector, Latvia's pharmaceutical market is re-emerging with steady growth forecast. Spending on pharmaceuticals will be driven by improved macroeconomic conditions. Meanwhile, the country's manufacturing sector should benefit from its anticipated membership of the eurozone, which remains on track.
View full press release